&lt;p&gt;Refractive Lens Exchange in Hyperopic Presbyopes with the Acrysof IQ Panoptix Intraocular Lens: One-Year Results and Analysis of the Literature&lt;/p&gt;

Nicula, Cristina; Popescu, Raluca; Rednik, Anca Maria; Nicula, D; Bulboacă, Adriana Elena; Stănescu, Ioana

doi:10.2147/tcrm.s279065

Cited by 10 publications

(8 citation statements)

References 31 publications

(76 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The accuracy between the predicted and the postoperative spherical equivalent was -0.10 ± 0.41 D, with 80.9% of the eyes within ± 0.5 D and 97.1% within ± 1.0 D of the predicted value. These results were consistent with the data recently published with the Versario 3F (Valeant Med Sp.z o.o, Warsaw, Poland) or the PanOptix (Alcon Inc., Fort Worth, USA) multifocal IOLs with, respectively, 72% and 82% of the eyes within ± 0.5 D of planned correction [25,26].…”

Section: Discussionsupporting

confidence: 92%

“…Fernández-García et al reported binocular values of 0.01 ± 0.02 logMAR, 0.02 ± 0.06 logMAR and 0.04 ± 0.05 logMAR for far, intermediate and near vision respectively, 3 months after implantation of the FineVision trifocal lens [ 24 ]. Nicula et al reported values better than 0.00 logMAR for all three distances 1 year after implantation of the AcrySof PanOptix (Alcon) [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Visual performance, safety and patient satisfaction after bilateral implantation of a trifocal intraocular lens in presbyopic patients without cataract

et al. 2022

View full text Add to dashboard Cite

Background The aim was to evaluate the safety and efficacy of a trifocal intraocular lens (IOL) for the correction of presbyopia and to assess patient satisfaction. Methods Records from three centres were reviewed to select presbyopic patients having undergone bilateral refractive lens exchange and implantation of the AT LISA tri 839MP multifocal IOL. Postoperatively, monocular and binocular distance, intermediate and near visual acuities, corrected and uncorrected, and subjective refraction were measured. Patients also completed a quality of life questionnaire. Safety evaluation included IOL stability and postoperative complications. Results 72 eyes (36 patients) were analysed. No clinically significant difference between pre- and postoperative corrected distance visual acuity (CDVA) was found for monocular or binocular measurements. Mean postoperative monocular CDVA was 0.02 ± 0.04 logMAR. Mean refractive values all improved statistically significantly compared with preoperative baseline (p ≤ 0.0064). Overall, 82.4% of eyes had spherical equivalent within ± 0.5 D and 97.1% within ± 1.0 D of emmetropia with a mean accuracy of -0.10 ± 0.41 D. Spectacle independence for distance, intermediate and near visual acuity was 87.5%, 84.4% and 78.1% respectively, and 78.1% of patients were satisfied with their postoperative, spectacle-free vision. Eight eyes received Nd:YAG laser treatment. No other IOL-related safety issues were reported. Conclusion AT LISA tri 839MP multifocal IOL bilaterally implanted in presbyopic patients provided excellent distance, intermediate and near visual outcomes with very accurate correction of refraction. These results were associated with a high level of spectacle independence and patient satisfaction. Trial registration Trial registered on https://clinicaltrials.gov/ under the identification NCT03790592 (31/12/2018).

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Visual performance, safety and patient satisfaction after bilateral implantation of a trifocal intraocular lens in presbyopic patients without cataract

et al. 2022

View full text Add to dashboard Cite

show abstract

“…This is an important distinction because compared to patients with cataract, RLE patients are likely to have higher expectations and greater sensitivity to postoperative visual disturbances, which warrants further characterization in this unique population. Only one other study has analyzed the visual outcomes of bilateral PanOptix implantation in RLE patients alone, but spectacle independence and visual disturbances were not addressed in detail [ 19 ]. Overall in our study, we found RLE with PanOptix implantation to be a safe and effective procedure in our patients mostly with hyperopia, presbyopia, and without cataract, similar to prior studies evaluating PanOptix IOL outcomes in cataract and mixed cataract + RLE study cohorts (Table 3 ) [ 13 , 15 – 24 ].…”

Section: Discussionmentioning

confidence: 99%

“…In contrast, several PanOptix studies previously reported lower rates of dysphotopsias. For example, Nicula et al cited a positive dysphotopsia rate of only 18.8% in their RLE patients, but their self-developed survey was limited and queried only about postoperative “halos and glittering” [ 19 ]. Another PanOptix study described only 1 out of 55 patients who reported “disturbing haloes,” but again their questionnaire was non-standardized, and their population included both RLE patients and patients with cataract [ 28 ].…”

Section: Discussionmentioning

confidence: 99%

Visual Outcomes and Patient Satisfaction After Bilateral Refractive Lens Exchange with a Trifocal Intraocular Lens in Patients with Presbyopia

et al. 2023

View full text Add to dashboard Cite

Introduction Refractive lens exchange (RLE) patients represent a unique population with a different baseline and set of expectations compared to their cataract counterparts. Visual outcomes and patient satisfaction following RLE with bilateral implantation of a trifocal intraocular lens (IOL) were assessed in a cohort of patients with presbyopia and without cataract. Methods Charts of patients with presbyopia who underwent femtosecond laser-assisted RLE with bilateral implantation of the PanOptix trifocal IOL (toric and non-toric) at a single-surgeon, private practice center from September 2019 to August 2020 were retrospectively reviewed. Eyes with prior keratorefractive surgery, amblyopia, or underlying pathology were excluded. Primary endpoints included corrected and uncorrected visual acuity at distance (CDVA and UDVA), intermediate (DCIVA and UIVA), and near (DCNVA and UNVA) at 6 months. Secondary endpoints included residual refractive error, patient-reported satisfaction, spectacle independence, and visual disturbance profile as assessed by a validated questionnaire at 6 months. Results Seventy-eight eyes of 39 patients (mean age 56 ± 6 years; 79% female) were included. Most eyes were hyperopic (mean SE 2.35 ± 1.81). Postoperatively, 100% and 92% of eyes were within ± 1.00 D and ± 0.50 D of emmetropia, respectively. One hundred percent, 97%, and 97% of patients achieved UDVA, UNVA, and UIVA of logMAR 0.1 or better. Starbursts were the most frequent (67%) and bothersome (41%) visual disturbance cited, but nearly half (41%) of patients rated them as absent or “not bothersome at all.” Overall, 77% of patients reported achieving complete spectacle independence with 87% and 90% of patients stating they were satisfied with their vision and would recommend the same procedure to others, respectively. Conclusions RLE with bilateral implantation of the PanOptix IOL is a safe and effective procedure with good patient satisfaction. Because of their relatively clear native lenses and visually demanding needs compared to their cataract counterparts, surgeons should take extra precautions to counsel RLE patients on the limitations of trifocal technology. Supplementary Information The online version contains supplementary material available at 10.1007/s40123-023-00708-x.

show abstract

“…Due to the loss of accommodation with RLE, presbyopic or "peripresbyopic" patients are more likely to benefit from the procedure than pre-presbyopes [29]. The literature suggests that 40-45 years should be the lower limit of the age range considered for RLE [30,31].…”

Section: Refractive Lens Exchangementioning

confidence: 99%

Choosing the right surgical treatment for hyperopia

Grzeszkowiak¹,

Wierzbowska

2022

Ophthatherapy

View full text Add to dashboard Cite

Several aspects make the treatment of hyperopia and selecting the treatment method challenging. This article has reviewed the main surgical options for hyperopia and factors that must be considered when choosing the right treatment. The modern refractive technology offers excellent options with the optimal choice of procedure being dependent on the level of refractive error, age of the patient and the unique anatomical factors in each case. Surgeons must perform a complete evaluation and risk-benefit assessment of the individual patient to select the best procedure.

show abstract

<p>Refractive Lens Exchange in Hyperopic Presbyopes with the Acrysof IQ Panoptix Intraocular Lens: One-Year Results and Analysis of the Literature</p>

Cited by 10 publications

References 31 publications

Visual performance, safety and patient satisfaction after bilateral implantation of a trifocal intraocular lens in presbyopic patients without cataract

Visual performance, safety and patient satisfaction after bilateral implantation of a trifocal intraocular lens in presbyopic patients without cataract

Visual Outcomes and Patient Satisfaction After Bilateral Refractive Lens Exchange with a Trifocal Intraocular Lens in Patients with Presbyopia

Choosing the right surgical treatment for hyperopia

Contact Info

Product

Resources

About